micro News and Research

RSS

MIPT researchers develop ultrasensitive nanomechanical sensor to identify tumor markers

Two young researchers working at the MIPT Laboratory of Nanooptics and Plasmonics, Dmitry Fedyanin and Yury Stebunov, have developed an ultracompact highly sensitive nanomechanical sensor for analyzing the chemical composition of substances and detecting biological objects, such as viral disease markers, which appear when the immune system responds to incurable or hard-to-cure diseases, including HIV, hepatitis, herpes, and many others.

10 Jun 2015

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Pivotal Therapeutics Inc., a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today the enrollment of the first patient in Pivotal's POMEGA Phase IIa clinical trial with PVT-100.

4 Jun 2015

Northeastern University researchers report two approaches to eradicate Lyme disease

Northeastern University researchers have found that the bacterium that causes Lyme disease forms dormant persister cells, which are known to evade antibiotics. This significant finding, they said, could help explain why it's so difficult to treat the infection in some patients.

2 Jun 2015

Contaminant particles emitted by vehicles have negative repercussions in children with respiratory illnesses

Particles of less than 2.5 microns emitted by vehicles have negative repercussions for bronchiolitis, pneumonia, asthma and bronchitis in children.

1 Jun 2015

Panasonic launch new high sensitivity micro camera head

The new GP-KH232HA micro camera-head benefits from a 1/3 type Full HD single MOS sensor, which can operate at a minimum illumination of just 5 lx at F1.4. Required illumination comprises solely 2000 lx at F8.

From PHC Europe B.V. 1 Jun 2015

RI-MUHC researchers receive innovations grants to build technologies to address cancer challenges

"Thanks to the Innovation Fund, our donors to the MGH Foundation and the vision of the Max Pacioretty Foundation, this new specialized MRI will place the Montreal General Hospital as one of the leading level 1 trauma centres in Canada. This valuable piece of healthcare technology will also allow our world-class researchers to better understand brain injuries, which will lead to improved patient diagnosis and treatment," adds Jean-Guy Gourdeau, President and Chief Executive Officer of the Montreal General Hospital Foundation at the MUHC.

1 Jun 2015

Nanopatch Jet Coating drug delivery platform wins 2015 Good Design Award

Invetech, a leader in instrument development, custom automation, and contract manufacturing, and Vaxxas, a biotechnology start-up and developer of the Nanopatch™ needle-free drug delivery technology, have been named winners of the 2015 Good Design Award for development of the Nanopatch Jet Coating Instrument, an advanced technology platform to support needle-free dermal drug delivery research and product development. The award was announced last evening at the Good Design Awards Gala Night held in Sydney, Australia.

1 Jun 2015

Leading researchers to gather at international nanotechnology conference in Birmingham

Leading researchers from across the globe will gather at Birmingham City University’s City Centre Campus on 9 June for the two-day ‘Advances in Nanotechnology’ event.

30 May 2015

Study expands understanding of the production of ET-743 compound

For decades, scientists have known that ET-743, a compound extracted from a marine invertebrate called a mangrove tunicate, can kill cancer cells. The drug has been approved for use in patients in Europe and is in clinical trials in the U.S.

29 May 2015

New investments may enable two Canadian organizations to improve life for people with hearing loss

New investments from public and private sources in Canada and the USA, including Grand Challenges Canada and Google.org, will enable two Canadian organizations to contribute to a better life for people with hearing loss in developing countries.

27 May 2015

Genocea reports positive results from GEN-003 Phase 2 clinical trial for treatment of genital herpes

Genocea Biosciences, Inc., a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced positive top-line data from a Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes.

21 May 2015

Non-coding micro RNA molecule may control chemotherapy resistance among ovarian cancer patients

A molecule that helps control gene expression may play a role in controlling chemotherapy resistance among patients with the most common form of ovarian cancer.

21 May 2015

Exact Imaging's ExactVu micro-ultrasound platform introduced at AUA 2015 Annual Meeting

Exact Imaging, the world's leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies of the prostate, today introduced its ExactVu high-resolution micro-ultrasound platform for prostate imaging and biopsy.

19 May 2015

Tandem Diabetes Care announces release of t:flex Insulin Pump

Tandem Diabetes Care, Inc., a medical device company and manufacturer of the t:slim Insulin Pump, today announced that it is now taking orders for the t:flex Insulin Pump, with shipments planned to begin in June. The 480-unit t:flex Pump, cleared by the U.S. Food and Drug Administration in January 2015, is the largest capacity insulin pump currently offered in the United States.

19 May 2015

Long, non-coding RNAs play a role in heart attacks, strokes and cancer

About 70 percent of our genes provide the blueprint for biomolecules whose function is only now being discovered - non-coding RNAs. Instead of being translated into proteins, they seem to perform steering functions in the body.

14 May 2015

New study discovers master switch that drives heart cell maturation process

A molecular switch that seems to be essential for embryonic heart cells to grow into more mature, adult-like heart cells has been discovered.

13 May 2015

Reducing protocol time for 96-well PCR Assays

The virus and prion validation group at Octapharma GmbH (Frankfurt, Germany) reports how implementing an INTEGRA VIAFLO 96 has enabled them to reduce the time taken to undertake PCR assays by greater than 60%...

From INTEGRA Biosciences 12 May 2015

Walnut-enriched diet may slow colorectal tumor growth

A new animal study from Beth Israel Deaconess Medical Center, Harvard Medical School, led by Dr. Christos Mantzoros, indicates that a diet containing walnuts may slow colorectal tumor growth by causing beneficial changes in cancer genes.

11 May 2015

Full range of Lab M media for detection and isolation of Listeria shown together for the first time

The document, ‘Listeria solutions… whatever your method’, clearly shows that whichever testing method users subscribe to, whatever the lab size, and whether they prefer dehydrated culture media...

8 May 2015

TESCAN introduce unique multimodal holographic microscope for live cell imaging

The unique Q-PHASE microscope is based on the principle of incoherent holography. Where other available solutions make use of a laser or laser diode, which may cause adverse or undesirable effects, mainly in terms of imaging quality, Q-PHASE uses white light for illumination, thus producing high quality imaging...

From Tescan 8 May 2015

micro News and Research

MIPT researchers develop ultrasensitive nanomechanical sensor to identify tumor markers

Pivotal Therapeutics enrolls first patient in POMEGA Phase IIa clinical trial of PVT-100

Northeastern University researchers report two approaches to eradicate Lyme disease

Contaminant particles emitted by vehicles have negative repercussions in children with respiratory illnesses

Panasonic launch new high sensitivity micro camera head

RI-MUHC researchers receive innovations grants to build technologies to address cancer challenges

Nanopatch Jet Coating drug delivery platform wins 2015 Good Design Award

Leading researchers to gather at international nanotechnology conference in Birmingham

Study expands understanding of the production of ET-743 compound

New investments may enable two Canadian organizations to improve life for people with hearing loss

Genocea reports positive results from GEN-003 Phase 2 clinical trial for treatment of genital herpes

Non-coding micro RNA molecule may control chemotherapy resistance among ovarian cancer patients

Exact Imaging's ExactVu micro-ultrasound platform introduced at AUA 2015 Annual Meeting

Tandem Diabetes Care announces release of t:flex Insulin Pump

Long, non-coding RNAs play a role in heart attacks, strokes and cancer

New study discovers master switch that drives heart cell maturation process

Reducing protocol time for 96-well PCR Assays

Walnut-enriched diet may slow colorectal tumor growth

Full range of Lab M media for detection and isolation of Listeria shown together for the first time

TESCAN introduce unique multimodal holographic microscope for live cell imaging

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News